Events, News, Presentations, Press Releases
Sutro Biopharma Announces Presentation of STRO-002 Data from the Compassionate Use Program in Pediatric Patients with Relapsed/Refractory CBF/GLIS AML at ASH 2022 – A total of 17 pediatric patients were treated with STRO-002 on a compassionate use basis; eight...